» Authors » Ilkka Kantola

Ilkka Kantola

Explore the profile of Ilkka Kantola including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 1084
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pisani A, Wilson K, Batista J, Kantola I, Ortiz A, Politei J, et al.
J Inherit Metab Dis . 2024 Jul; 47(5):1080-1095. PMID: 38961737
Fabry Registry data were analyzed among 83 agalsidase beta-treated patients with Fabry disease who switched to migalastat. Outcomes (estimated glomerular filtration rate [eGFR], urine protein-creatinine ratio [UPCR], plasma globotriaosylceramide [GL-3],...
2.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
Blood Press . 2024 Jun; 33(1):2368800. PMID: 38910347
Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A...
3.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
J Hypertens . 2024 May; 42(9):1544-1554. PMID: 38747416
Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management...
4.
Kaisti M, Panula T, Sirkia J, Pankaala M, Koivisto T, Niiranen T, et al.
Adv Sci (Weinh) . 2024 Apr; 11(24):e2307718. PMID: 38647263
Results from two independent clinical validation studies for measuring hemodynamics at the patient's bedside using a compact finger probe are reported. Technology comprises a barometric pressure sensor, and in one...
5.
Panula T, Sirkia J, Koivisto T, Pankaala M, Niiranen T, Kantola I, et al.
iScience . 2023 Nov; 26(11):108295. PMID: 38026187
Our aim is to develop a blood pressure (BP) measurement technology that could be integrated into a finger-worn pulse oximeter, eliminating the need for a brachial cuff. We present a...
6.
Wallace E, Goker-Alpan O, Wilcox W, Holida M, Bernat J, Longo N, et al.
J Med Genet . 2023 Nov; 61(6):520-530. PMID: 37940383
Background: Pegunigalsidase alfa is a PEGylated α-galactosidase A enzyme replacement therapy. BALANCE (NCT02795676) assessed non-inferiority of pegunigalsidase alfa versus agalsidase beta in adults with Fabry disease with an annualised estimated...
7.
Metsarinne K, Pietila M, Kantola I, K Stenman L, Vesikansa A, Ruokolainen L, et al.
Prim Care Diabetes . 2023 Oct; 17(6):632-638. PMID: 37891057
Aims: To study the association between risk factors and chronic kidney disease (CKD), and characterize medication use in Finnish primary care type 2 diabetes (T2D) patients. Methods: Data on clinical...
8.
Burlina A, Brand E, Hughes D, Kantola I, Krmer J, Nowak A, et al.
Mol Genet Metab . 2023 May; 139(2):107585. PMID: 37207471
Fabry disease is an X-linked lysosomal storage disorder caused by the accumulation of glycosphingolipids in various tissues and body fluids, leading to progressive organ damage and life-threatening complications. Phenotypic classification...
9.
Pietila-Effati P, Saarinen J, Loyttyniemi E, Saarenhovi M, Autio R, Kantola I
Am J Med Genet A . 2023 Apr; 191(7):1858-1869. PMID: 37078610
Fabry disease (FD) is an X chromosome-linked, life-threatening lysosomal disease caused by one of more than 1000 currently known variants in the α-galactosidase A (GLA) gene. The follow-up part of...
10.
Valtola K, Hedman M, Kantola I, Walls S, Helisalmi S, Maria M, et al.
Open Heart . 2023 Mar; 10(1). PMID: 36927868
Objective: To present phenotypic characteristics and biomarkers of a family with the rare mutation Thr410Ala of the gene (T410A/) causing Fabry disease (FD). Methods And Results: In a woman in...